Temat: "hepatitis C-chronic" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Evaluating hepatitis C cascade of care surveillance system in Tuscany, Italy, through a population retrospective data-linkage study, 2015-2021.
Autorzy:: Ceccarelli L; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. .; Management and Healthcare Laboratory, Sant'Anna School of Advanced Studies, Pisa, Italy. .
Moretti G; Management and Healthcare Laboratory, Sant'Anna School of Advanced Studies, Pisa, Italy.
Mazzilli S; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Scuola Normale Superiore, Pisa, Italy.
Petri D; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Corazza I; Management and Healthcare Laboratory, Sant'Anna School of Advanced Studies, Pisa, Italy.
Rizzo C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Lucenteforte E; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Vainieri M; Management and Healthcare Laboratory, Sant'Anna School of Advanced Studies, Pisa, Italy.
Seghieri C; Management and Healthcare Laboratory, Sant'Anna School of Advanced Studies, Pisa, Italy.
Tavoschi L; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.; Pokaż więcej
Corporate Authors:: OPT-HepaC consortium
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Mar 29; Vol. 24 (1), pp. 362. Date of Electronic Publication: 2024 Mar 29.
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis C, Chronic*/diagnosis
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Hepatitis C*/diagnosis
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Substance Abuse, Intravenous*/epidemiology
Male ; Pregnancy ; Female ; Humans ; Hepacivirus ; Retrospective Studies ; Antiviral Agents/therapeutic use ; Pandemics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Impact of ITPA gene polymorphism for predicting anemia and treatment outcome in HCV infected patients taking Sofosbuvir Ribavirin therapy.
Autorzy:: Amjed S; University Institute of Medical Laboratory Technology, Faculty of Allied Health Sciences, The University of Lahore, Raiwind Road Campus, Lahore, Pakistan. .; Medical Laboratory Technology Department, Faculty of Rehabilitation and Allied Health Sciences, RIPHAH International University, Gulberg Campus, Lahore, Pakistan. .
Saleem HGM; University Institute of Medical Laboratory Technology, Faculty of Allied Health Sciences, The University of Lahore, Raiwind Road Campus, Lahore, Pakistan.; Medical Laboratory Technology Department, Faculty of Rehabilitation and Allied Health Sciences, RIPHAH International University, Gulberg Campus, Lahore, Pakistan.
Ullah S; University Institute of Medical Laboratory Technology, Faculty of Allied Health Sciences, The University of Lahore, Raiwind Road Campus, Lahore, Pakistan.
Latif S; Gastroenterology Department, Akthar Saeed Medical and Dental College, Lahore, Pakistan.
Shabana; Department of Microbiology and Molecular Genetics, University of the Punjab, Lahore, Pakistan.
Jafar J; Specilized Health Care and Medical Education Department, Lahore, Punjab, Pakistan.
Waqar AB; University Institute of Medical Laboratory Technology, Faculty of Allied Health Sciences, The University of Lahore, Raiwind Road Campus, Lahore, Pakistan.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Mar 11; Vol. 24 (1), pp. 301. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/genetics
Anemia*/chemically induced
Anemia*/genetics
Hepatitis C*/drug therapy
Humans ; Ribavirin/adverse effects ; Sofosbuvir/adverse effects ; Antiviral Agents/adverse effects ; Inosine Triphosphatase ; Hepacivirus/genetics ; Prospective Studies ; Polymorphism, Single Nucleotide ; Pyrophosphatases/genetics ; Pyrophosphatases/therapeutic use ; Genotype ; Hemoglobins/genetics ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: High prevalence of fatty liver and its association with metabolic syndrome among rural adults with chronic hepatitis C: Implications for primary healthcare.
Autorzy:: Wang TJ; Department of Diagnostic Radiology, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Chen MY; Department of Nursing, Chang Gung University of Science and Technology, Chiayi, Taiwan.; Department of Cardiology, Chang Gung Memorial Hospital, Chiayi, Taiwan.; School of Nursing, Chang Gung University, Taoyuan, Taiwan.
Lin YC; Department of Family Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Chiu WN; Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan.
Huang TJ; Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan.; Department of Respiratory Care, Chang Gung University of Science and Technology, Chiayi, Taiwan.
Weng HH; Department of Diagnostic Radiology, Chang Gung Memorial Hospital, Chiayi, Taiwan. .; Department of Nursing, Chang Gung University of Science and Technology, Chiayi, Taiwan. .; College of Medicine, Chang Gung University, Taoyuan, Taiwan. .; Pokaż więcej
Źródło:: BMC public health [BMC Public Health] 2024 Feb 20; Vol. 24 (1), pp. 532. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:: Journal Article
MeSH Terms:: Metabolic Syndrome*
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/epidemiology
Hepatitis C, Chronic*/diagnosis
Fatty Liver*/diagnostic imaging
Fatty Liver*/epidemiology
Diabetes Mellitus*
Hypertension*/complications
Cardiovascular Diseases*/complications
Liver Neoplasms*
Adult ; Humans ; Child ; Risk Factors ; Prevalence ; Blood Glucose ; Cross-Sectional Studies ; Obesity/epidemiology ; Biomarkers ; Cholesterol ; Lipoproteins, HDL ; Primary Health Care

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study.
Autorzy:: Druckrey-Fiskaaen KT; Bergen Addiction Research, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway. .; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. .
Vold JH; Bergen Addiction Research, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.; Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
Madebo T; Bergen Addiction Research, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Respiratory Medicine, Stavanger University Hospital, Stavanger, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway.
Midgard H; Department of Gastroenterology, Oslo University Hospital, Oslo, Norway.
Dalgard O; Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway.
Leiva RA; Department of Infectious Diseases, Haukeland University Hospital, Bergen, Norway.
Fadnes LT; Bergen Addiction Research, Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.; Pokaż więcej
Corporate Authors:: INTRO-HCV Study Group
Źródło:: Substance abuse treatment, prevention, and policy [Subst Abuse Treat Prev Policy] 2024 Mar 26; Vol. 19 (1), pp. 21. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/pathology
Hepatitis C, Chronic*/epidemiology
Hepatitis C*/complications
Substance-Related Disorders*/complications
Humans ; Child ; Prospective Studies ; Liver/pathology ; Liver Cirrhosis/epidemiology ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Effects of sustained viral response on lipid in Hepatitis C: a systematic review and meta-analysis.
Autorzy:: Mei T; Interventional Therapy Center for Oncology Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Huang X; Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Tang S; Department of Liver Disease, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Liu M; State Clinical Drug Trial Institution, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Zhang W; State Clinical Drug Trial Institution, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.
Yu H; State Clinical Drug Trial Institution, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China. .; Pokaż więcej
Źródło:: Lipids in health and disease [Lipids Health Dis] 2024 Mar 09; Vol. 23 (1), pp. 74. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:: Hepatitis C*/drug therapy
Hepatitis C, Chronic*/drug therapy
Humans ; Antiviral Agents/therapeutic use ; Hepacivirus/genetics ; Lipids

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: The deleterious effects of sofosbuvir and ribavirin (antiviral drugs against hepatitis C virus) on different body systems in male albino rats regarding reproductive, hematological, biochemical, hepatic, and renal profiles and histopathological changes.
Autorzy:: Ali RA; Zoology Department, Faculty of Science, South Valley University, Qena, Egypt.
Awadalla EA; Zoology Department, Faculty of Science, Aswan University, Aswan, Egypt.
Amin YA; Department of Theriogenology, Faculty of Veterinary Medicine, Aswan University, Aswan, Egypt. .
Fouad SS; Qena University Hospital, South Valley University, Qena, Egypt.
Ahmed MAB; Department of Anatomy, Faculty of Medicine, South Valley University, Qena, Egypt.
Hassan MH; Department of Medical Biochemistry, Faculty of Medicine, South Valley University, Qena, Egypt.
Abdel-Kahaar E; Department of Medical Pharmacology, Faculty of Medicine, South Valley University, Qena, Egypt.; Institute of Clinical Pharmacology, Medical Faculty Mannheim, Ruprecht-Karls-University, Heidelberg, Germany.
Abdel-Aziz RH; Department of Medical Physiology, Faculty of Medicine, South Valley University, Qena, Egypt.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 07; Vol. 14 (1), pp. 5682. Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis C, Chronic*/drug therapy
Pancreatitis*/chemically induced
Humans ; Adult ; Child ; Male ; Animals ; Rats ; Antiviral Agents/adverse effects ; Sofosbuvir/adverse effects ; Ribavirin/therapeutic use ; Hepacivirus/genetics ; Acute Disease ; Treatment Outcome ; Drug Therapy, Combination ; Semen ; Sperm Motility ; Liver Cirrhosis/complications ; Lipase/genetics ; Genotype

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based Study.
Autorzy:: Passos-Castilho AM; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.; Department of Medicine, McGill University, Montreal, QC H3G 2M1, Canada.
Murphy DG; Laboratoire de Santé Publique du Québec, Institut National de Santé Publique du Québec, Sainte-Anne-de-Bellevue, QC H9X 3R5, Canada.
Blouin K; Unité sur les Infections Transmissibles Sexuellement et par le Sang, Institut National de Santé Publique du Québec, Québec, QC H9X 3R5, Canada.
Benedetti A; Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, QC H3A 1G1, Canada.
Panagiotoglou D; Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, McGill University, Montreal, QC H3A 1G1, Canada.
Bruneau J; CHUM Research Centre, Centre Hospitalier de l'Université de Montréal, Montreal, QC H2X 0A9, Canada.
Klein MB; Research Institute of the McGill University Health Centre, Montreal, QC H3H 2R9, Canada.
Kwong JC; Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada.; ICES, Toronto, ON M4N 3M5, Canada.; Public Health Ontario, Toronto, ON M5G 1M1, Canada.; Department of Family and Community Medicine, University of Toronto, Toronto, ON M5G 1V7, Canada.
Sander B; ICES, Toronto, ON M4N 3M5, Canada.; Public Health Ontario, Toronto, ON M5G 1M1, Canada.; Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 2C4, Canada.; Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto, Toronto, ON M5T 3M6, Canada.
Janjua NZ; School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Greenaway C; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.; Department of Medicine, McGill University, Montreal, QC H3G 2M1, Canada.; Division of Infectious Diseases, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Mar 01; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis C, Chronic*/drug therapy
Hepatitis C*/diagnosis
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Humans ; Hepacivirus/genetics ; Antiviral Agents/therapeutic use ; Retrospective Studies ; Cohort Studies ; Canada/epidemiology ; RNA

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Integration of Hepatitis C and Addiction Treatment in People Who Inject Drugs: The San Patrignano HCV-Free and Drug-Free Experience.
Autorzy:: Piselli P; Clinical Epidemiology Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Boschini A; Medical Center, Comunità di S. Patrignano, 47853 Coriano, RN, Italy.
Gianfreda R; Infectious Disease Unit, Hospital of Rimini 'Gli Infermi', 47923 Rimini, Italy.
Nappo A; Clinical Epidemiology Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Cimaglia C; Clinical Epidemiology Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Scarfò G; Clinical Epidemiology Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
Smacchia C; Medical Center, Comunità di S. Patrignano, 47853 Coriano, RN, Italy.
Paoletti R; Medical Center, Comunità di S. Patrignano, 47853 Coriano, RN, Italy.
Duehren S; Medical Center, Comunità di S. Patrignano, 47853 Coriano, RN, Italy.
Girardi E; Clinical Epidemiology Unit, Department of Epidemiology and Preclinical Research, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Feb 28; Vol. 16 (3). Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:: Journal Article
MeSH Terms:: Drug Users*
Hepatitis C, Chronic*/drug therapy
Substance Abuse, Intravenous*/complications
Hepatitis C*/diagnosis
Hepatitis C*/drug therapy
Humans ; Hepacivirus/genetics ; Antiviral Agents/therapeutic use ; Reinfection ; RNA

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Effects of HCV Clearance with Direct-Acting Antivirals (DAAs) on Liver Stiffness, Liver Fibrosis Stage and Metabolic/Cellular Parameters.
Autorzy:: Ferreira J; Institute for Scientific Research Bento Rocha Cabral, 1250-047 Lisbon, Portugal.; TERRA, ISAMB, Genetics Laboratory, Lisbon Medical School, University of Lisbon, 1649-028 Lisbon, Portugal.
Bicho M; Institute for Scientific Research Bento Rocha Cabral, 1250-047 Lisbon, Portugal.; TERRA, ISAMB, Genetics Laboratory, Lisbon Medical School, University of Lisbon, 1649-028 Lisbon, Portugal.
Serejo F; TERRA, ISAMB, Genetics Laboratory, Lisbon Medical School, University of Lisbon, 1649-028 Lisbon, Portugal.; Gastroenterology and Hepatology Department, Hospital de Santa Maria, 1649-028 Lisbon, Portugal.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Feb 27; Vol. 16 (3). Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis C, Chronic*
Insulin Resistance*
Iron Overload*/complications
Iron Overload*/drug therapy
Humans ; Antiviral Agents/therapeutic use ; Antiviral Agents/pharmacology ; Liver Cirrhosis/etiology ; Inflammation/drug therapy ; Iron ; Cholesterol

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study.
Autorzy:: Lopes SS; Department of Public Health Sciences, Clemson University, 29634, Clemson, SC, USA.
Pericot-Valverde I; Department of Psychology, College of Behavioral, Social, and Health Sciences, Clemson University, 29634, Clemson, SC, USA.
Lum PJ; Department of Medicine, University of California, San Francisco, 1001 Potrero Ave, 94110, San Francisco, CA, USA.
Taylor LE; Department of Pharmacy Practice and Clinical Research, University of Rhode Island, 7 Greenhouse Road, 02881, Kingston, RI, USA.
Mehta SH; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Room E6546, 21205, Baltimore, MD, USA.
Tsui JI; Department of Medicine, University of Washington, 325 9th Ave, 98104, Seattle, WA, USA.
Feinberg J; Department of Behavioral Medicine and Psychiatry, West Virginia University School of Medicine, 930 Chestnut Ridge Road, 26505, Morgantown, WV, USA.; Department of Medicine, Section of Infectious Diseases, West Virginia University School of Medicine, 1 Medical Center Drive, 26506, Morgantown, WV, USA.
Kim AY; Division of Infectious Diseases, Massachusetts General Hospital, 55 Fruit St, 02114, Boston, MA, USA.; Harvard Medical School, 02115, Boston, MA, USA.
Norton BL; Albert Einstein College of Medicine, 10461, Bronx, NY, USA.; Department of Medicine, Montefiore Medical Center, 10467, Bronx, NY, USA.
Page K; Department of Internal Medicine, Health Sciences Center, University of New Mexico, University of New Mexico, MSC 10, 5550, 87131, Albuquerque, NM, USA.
Murray-Krezan C; Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, 15213, Pittsburgh, PA, USA.
Anderson J; Department of Internal Medicine, Health Sciences Center, University of New Mexico, University of New Mexico, MSC 10, 5550, 87131, Albuquerque, NM, USA.
Karasz A; UMass Chan Medical School, University of Massachusetts Medical School, 55 Lake Ave, North, 01605, Worcester, MA, USA.
Arnsten J; Albert Einstein College of Medicine, 10461, Bronx, NY, USA.; Department of Medicine, Montefiore Medical Center, 10467, Bronx, NY, USA.
Moschella P; Department of Emergency Medicine, Prisma Health, Greenville, SC, USA.; School of Health Research, Clemson University, Clemson, SC, USA.; Department of Medicine, University of South Carolina School of Medicine, 876 W Faris Rd, 29605, Greenville, SC, USA.
Heo M; Department of Public Health Sciences, Clemson University, 29634, Clemson, SC, USA.
Litwin AH; School of Health Research, Clemson University, Clemson, SC, USA. .; Department of Medicine, University of South Carolina School of Medicine, 876 W Faris Rd, 29605, Greenville, SC, USA. .; Department of Medicine, Prisma Health, 29605, Greenville, SC, USA. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Feb 23; Vol. 24 (1), pp. 251. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:: Journal Article
MeSH Terms:: Drug Users*
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/drug therapy
Hepatitis C, Chronic*/drug therapy
Hepatitis C*/drug therapy
Hepatitis C*/complications
Humans ; Antiviral Agents/therapeutic use ; Hepacivirus/genetics ; Sustained Virologic Response

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Comparative efficacy and safety of Sofosbuvir/Velpatasvir and Danoprevir for the treatment of chronic hepatitis C: the real-world data in China.
Autorzy:: Zhou Y; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, No. 600 Tianhe Road , 510630, Guangzhou City, Guangdong Province, China.
Liang M; Department of Infectious disease, The First people's hospital of Foshan, Foshan City, Guangdong Province, China.
Li Y; Department of General Practice, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou City, Guangdong Province, China.
Chen X; Department of Infectious Diseases, Yangjiang Public Health Hospital, Yangjiang City, Guangdong Province, China.
Yang J; Clinical Medicine Department of Southwest Medical University, Luzhou City, Sichuan Province, China.
Bai H; Department of Infectious disease, The First people's hospital of Foshan, Foshan City, Guangdong Province, China.
Long Y; Department of Infectious Diseases, The Eighth Hospital of Guangzhou Medical University, Guangzhou City, Guangdong Province, China.
Zhang X; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, No. 600 Tianhe Road , 510630, Guangzhou City, Guangdong Province, China.
Lin C; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, No. 600 Tianhe Road , 510630, Guangzhou City, Guangdong Province, China. .; Pokaż więcej
Źródło:: BMC gastroenterology [BMC Gastroenterol] 2024 Feb 14; Vol. 24 (1), pp. 73. Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Benzimidazoles*
Benzopyrans*
Carbamates*
Cyclopropanes*
Drug Combinations*
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/genetics
Isoindoles*
Lactams, Macrocyclic*
Proline*/analogs & derivatives
Sulfonamides*
Humans ; Antiviral Agents/adverse effects ; China ; Genotype ; Hepacivirus/genetics ; Heterocyclic Compounds, 4 or More Rings/adverse effects ; Liver Cirrhosis/drug therapy ; Retrospective Studies ; Ribavirin/adverse effects ; Sofosbuvir/adverse effects ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver fibrosis.
Autorzy:: Hildenbrand FF; Division of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.; Division of Gastroenterology and Hepatology, Stadtspital Zurich, Zurich, Switzerland.
Illi B; Division of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
von Felten S; Department of Biostatistics, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Bachofner J; Division of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Gawinecka J; Institute of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
von Eckardstein A; Institute of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Müllhaupt B; Division of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Mertens JC; Center of Gastroenterology, Klinik Hirslanden, Zurich, Switzerland.
Blümel S; Division of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland. .; Pokaż więcej
Źródło:: BMC gastroenterology [BMC Gastroenterol] 2024 Jan 30; Vol. 24 (1), pp. 54. Date of Electronic Publication: 2024 Jan 30.
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/pathology
Elasticity Imaging Techniques*
Humans ; Cohort Studies ; Aspartate Aminotransferases ; Liver Cirrhosis ; Liver/pathology ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong.
Autorzy:: Chow VYS; Our Lady of Maryknoll Hospital, Hong Kong, China. .
Cheung WI; Our Lady of Maryknoll Hospital, Hong Kong, China.; Pokaż więcej
Źródło:: BMC gastroenterology [BMC Gastroenterol] 2024 Jan 25; Vol. 24 (1), pp. 49. Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/epidemiology
Carcinoma, Hepatocellular*/etiology
Carcinoma, Hepatocellular*/pathology
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Liver Neoplasms*/epidemiology
Liver Neoplasms*/etiology
Liver Neoplasms*/pathology
Humans ; Antiviral Agents/therapeutic use ; alpha-Fetoproteins/analysis ; Hong Kong/epidemiology ; Liver Cirrhosis/complications ; Fibrosis ; Sustained Virologic Response

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Does a simplified algorithm and integrated HCV care model improve linkage to care, retention, and cure among people who inject drugs? A pragmatic quality improvement randomized controlled trial protocol.
Autorzy:: Klaman SL; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Godino JG; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA. .
Northrup A; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Lewis SV; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Tam A; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Carrillo C; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Lewis R; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Matthews E; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Mendez B; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Reyes L; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Rojas S; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.
Ramers C; Laura Rodriguez Research Institute - Family Health Centers of San Diego, 1750 Fifth Avenue, San Deigo, CA, 92101, USA.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Jan 19; Vol. 24 (1), pp. 105. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:: Clinical Trial Protocol; Journal Article
MeSH Terms:: Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Substance Abuse, Intravenous*/complications
Substance Abuse, Intravenous*/drug therapy
Drug Users*
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Adult ; Humans ; Hepacivirus ; Antiviral Agents/therapeutic use ; Prospective Studies ; Quality Improvement ; Seroepidemiologic Studies ; Algorithms ; Randomized Controlled Trials as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Prediction of Hepatocellular Carcinoma Development in Korean Patients after Hepatitis C Cure with Direct-Acting Antivirals.
Autorzy:: Hong H; Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Choi WM; Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Lee D; Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Shim JH; Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Kim KM; Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Lim YS; Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Lee HC; Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Choi J; Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; Pokaż więcej
Źródło:: Gut and liver [Gut Liver] 2024 Jan 15; Vol. 18 (1), pp. 147-155. Date of Electronic Publication: 2023 Apr 20.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*
Liver Neoplasms*/etiology
Liver Neoplasms*/complications
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Hepatitis C*/drug therapy
Humans ; Male ; Middle Aged ; Female ; Antiviral Agents/therapeutic use ; Hepacivirus ; Retrospective Studies ; Liver Cirrhosis ; Sustained Virologic Response ; Albumins ; Bilirubin/therapeutic use ; Republic of Korea/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Cholestatic HCV Cryoglobulinemia: A New Clinical and Pathological Entity before and after Direct-Acting Antiviral Therapies-A Case-Control Study.
Autorzy:: Ammendola S; Division of Pathology, Department of Diagnostics and Public Health, Azienda Ospedaliera Universitaria Integrata of Verona, 37134 Verona, Italy.
Romeo S; Division of General Medicine C, Department of Medicine, Azienda Ospedaliera Universitaria Integrata of Verona, 37134 Verona, Italy.; Liver Unit, Department of Medicine, University of Verona, 37129 Verona, Italy.
Cattazzo F; Division of General Medicine C, Department of Medicine, Azienda Ospedaliera Universitaria Integrata of Verona, 37134 Verona, Italy.; Liver Unit, Department of Medicine, University of Verona, 37129 Verona, Italy.
Mantovani A; Division of General Medicine C, Department of Medicine, Azienda Ospedaliera Universitaria Integrata of Verona, 37134 Verona, Italy.; Liver Unit, Department of Medicine, University of Verona, 37129 Verona, Italy.
Ieluzzi D; Division of General Medicine C, Department of Medicine, Azienda Ospedaliera Universitaria Integrata of Verona, 37134 Verona, Italy.; Liver Unit, Department of Medicine, University of Verona, 37129 Verona, Italy.
Paon V; Division of General Medicine C, Department of Medicine, Azienda Ospedaliera Universitaria Integrata of Verona, 37134 Verona, Italy.; Liver Unit, Department of Medicine, University of Verona, 37129 Verona, Italy.
Montagnana M; Section of Clinical Biochemistry, Department of Neurological, Biomedical and Movement Sciences, University of Verona, 37129 Verona, Italy.
Pecori S; Division of Pathology, Department of Diagnostics and Public Health, Azienda Ospedaliera Universitaria Integrata of Verona, 37134 Verona, Italy.
Tomezzoli A; Division of Pathology, Department of Diagnostics and Public Health, Azienda Ospedaliera Universitaria Integrata of Verona, 37134 Verona, Italy.
Dalbeni A; Division of General Medicine C, Department of Medicine, Azienda Ospedaliera Universitaria Integrata of Verona, 37134 Verona, Italy.; Liver Unit, Department of Medicine, University of Verona, 37129 Verona, Italy.
Sacerdoti D; Liver Unit, Department of Medicine, University of Verona, 37129 Verona, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 08; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 08.
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Cryoglobulinemia*/drug therapy
Cryoglobulinemia*/etiology
Hepatitis C*/complications
Hepatitis C*/drug therapy
Cholestasis*/complications
Cholestasis*/drug therapy
Male ; Humans ; Middle Aged ; Antiviral Agents/therapeutic use ; Case-Control Studies ; Retrospective Studies ; Biomarkers ; RNA

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Effect of integrated hepatitis C virus treatment on psychological distress in people with substance use disorders.
Autorzy:: Aas CF; Department of Addiction Medicine, Haukeland University Hospital, Jonas Lies vei 65, 5021, Bergen, Norway. .; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. .; Division of Psychiatry, Haukeland University Hospital, Bergen, Norway. .
Vold JH; Department of Addiction Medicine, Haukeland University Hospital, Jonas Lies vei 65, 5021, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.; Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.
Chalabianloo F; Department of Addiction Medicine, Haukeland University Hospital, Jonas Lies vei 65, 5021, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Løberg EM; Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Psychology, University of Bergen, Bergen, Norway.
Lim AG; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Vickerman P; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Johansson KA; Department of Addiction Medicine, Haukeland University Hospital, Jonas Lies vei 65, 5021, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Fadnes LT; Department of Addiction Medicine, Haukeland University Hospital, Jonas Lies vei 65, 5021, Bergen, Norway.; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Jan 08; Vol. 14 (1), pp. 816. Date of Electronic Publication: 2024 Jan 08.
Typ publikacji:: Randomized Controlled Trial; Multicenter Study; Journal Article
MeSH Terms:: Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Hepatitis C*/complications
Hepatitis C*/drug therapy
Substance-Related Disorders*/complications
Psychological Distress*
Humans ; Hepacivirus ; Antiviral Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Predictors of survival among patients with chronic hepatitis C at a tertiary care center in Oman.
Autorzy:: Al-Shuaili HH; Department of Medicine, Ibri Hospital, Ibri, Oman.
Al-Busafi SA; Department of Medicine, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.
Al-Naamani K; Department of Medicine, Armed Forces Hospital, Muscat, Oman.
Al-Naamani Z; Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman.; Pokaż więcej
Źródło:: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association [Saudi J Gastroenterol] 2024 Jan 01; Vol. 30 (1), pp. 45-52. Date of Electronic Publication: 2023 Sep 20.
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/epidemiology
Carcinoma, Hepatocellular*/epidemiology
Liver Neoplasms*/epidemiology
Humans ; Male ; Female ; Tertiary Care Centers ; Oman/epidemiology ; Cohort Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024.
Autorzy:: Alghamdi AS; Department of Medicine, Gastroenterology Unit, King Fahad Hospital, Jeddah, Saudi Arabia.
Alghamdi H; Hepatology Section, Hepatobiliary Sciences and Organs Transplant Center, King Abdulaziz Medical City, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Alserehi HA; General Directorate of Communicable Diseases, Ministry of Health, Riyadh, Saudi Arabia.
Babatin MA; Department of Medicine, Gastroenterology Unit, King Fahad Hospital, Jeddah, Saudi Arabia.
Alswat KA; Liver Disease Research Center, and Riyadh, Saudi Arabia.; College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Alghamdi M; Department of Medicine, Division of Gastroenterology, King Fahd Military Complex, Dhahran, Saudi Arabia.
AlQutub A; Department of Gastroenterology and Hepatology, King Fahad Medical City, Riyadh, Saudi Arabia.
Abaalkhail F; Department of Medicine, Section of Gastroenterology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.; College of Medicine, Al Faisal University, Riyadh, Saudi Arabia.
Altraif I; Hepatology Section, Hepatobiliary Sciences and Organs Transplant Center, King Abdulaziz Medical City, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Alfaleh FZ; Liver Disease Research Center, and Riyadh, Saudi Arabia.
Sanai FM; Liver Disease Research Center, and Riyadh, Saudi Arabia.; Gastroenterology Section, Department of Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia.; Pokaż więcej
Źródło:: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association [Saudi J Gastroenterol] 2024 Jan 01; Vol. 30 (Supp 1), pp. S1-S42. Date of Electronic Publication: 2024 Jan 03.
Typ publikacji:: Review; Journal Article
MeSH Terms:: Hepatitis C*/diagnosis
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Liver Transplantation*
Liver Neoplasms*
Hepatitis C, Chronic*/diagnosis
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Humans ; Hepacivirus ; Risk Factors ; Antiviral Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?
Autorzy:: Sacco M; Gastro-Hepatoloy Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Ribaldone DG; Gastro-Hepatoloy Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Saracco GM; Gastro-Hepatoloy Unit, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.; Pokaż więcej
Źródło:: Viruses [Viruses] 2023 Dec 17; Vol. 15 (12). Date of Electronic Publication: 2023 Dec 17.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Carcinoma, Hepatocellular*/epidemiology
Carcinoma, Hepatocellular*/etiology
Carcinoma, Hepatocellular*/prevention & control
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Liver Neoplasms*/epidemiology
Liver Neoplasms*/etiology
Liver Neoplasms*/prevention & control
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Metformin*/therapeutic use
Humans ; Antiviral Agents/therapeutic use ; Cohort Studies ; Prospective Studies ; Risk Reduction Behavior

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""hepatitis C-chronic"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język